MDT
Medtronic Plc
NYSE · Healthcare · Medical - Devices · IE
$92.77
−2.09%Year over year
Reported trailing growth
- Revenue
- +9.8%
- EBITDA
- +8.9%
- EBIT
- +10.8%
- EPS
- +12.7%
- Free cash flow
- +15.6%
- Operating cash flow
- +12.4%
Forward estimates
Based on analyst estimates
- Revenue
- +4.1%
- EBITDA
- +29.8%
- EPS
- +46.9%
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- +4.1%
- EBIT
- +5.6%
- Net income
- +8.5%
- EPS
- +9.8%
- Free cash flow
- +5.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026